drugset / Trial / NCT04539548
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery for pediatric cataract.
Timeline
- Start
- 2020-09-04
- Primary completion
- 2023-12-21
- Completion
- 2023-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextenza Ophthalmic Insert | Unknown | 0.4 mg | Other |
| Comparator | Prednisolone | Other / unclassified | 1 % | Topical |